| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.19 | 0.2 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |